Showing results (1311-1320 of 14,263) with videos related to
Sort By:
Pageof 1,427
Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.Diabetes|April 28, 2011
HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cellsFatima Whitfield-Larry, Ellen F Young, Garrick Talmage, et al.Diabetes|April 19, 2011
Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humansPierre-Marie Badin, Katie Louche, Aline Mairal, et al.Diabetes|May 4, 2011
Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1Courtney M Macmullen, Qing Zhou, Kara E Snider, et al.Diabetes|June 8, 2011
Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistanceNirupa Sachithanandan, Kate L Graham, Sandra Galic, et al.Diabetes|June 8, 2011
Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassemblyYing Wang, Prasanth Puthanveetil, Fang Wang, et al.Diabetes|June 8, 2011
Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetesEster Badami, Chiara Sorini, Margherita Coccia, et al.Diabetes|May 28, 2011
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC studyEleni Rebelos, Elza Muscelli, Andrea Natali, et al.Diabetes|May 28, 2011
Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytesLucía Serrano-Marco, Ricardo Rodríguez-Calvo, Ilhem El Kochairi, et al.Diabetes|May 28, 2011
Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin toleranceHyun-Seuk Moon, Giuseppe Matarese, Aoife M Brennan, et al.Pageof 1,427